Inhibition MNK‐eIF4E‐β‐catenin preferentially sensitizes gastric cancer to chemotherapy-Reference-Cited by-同舟云学术

Inhibition MNK‐eIF4E‐β‐catenin preferentially sensitizes gastric cancer to chemotherapy

Published:2022-01-26 Issue:4 Volume:36 Page:712-720
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Yang Xiaolin¹,Liu Zhenyang¹,Yin Xianli¹,Zeng Yidong¹,Guo Geyang²^ORCID

Affiliation:

1. Department of Gastroenterology and Urology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

2. Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12759

Reference28 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Progress in the treatment of advanced gastric cancer

3. Molecularly Targeted Therapies for Gastric Cancer. State of the Art

4. Molecular Pathology of Gastroesophageal Cancer

5. The impact of recent next generation sequencing and the need for a new classification in gastric cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective and effective suppression of pancreatic cancer through MNK inhibition;Immunopharmacology and Immunotoxicology;2024-08-13

2. MNK: A Novel Promising Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-01-16

3. Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process;PLOS Biology;2023-11-09

4. Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy;Journal of Medicinal Chemistry;2023-09-19

5. MNK Proteins as Therapeutic Targets in Leukemia;OncoTargets and Therapy;2023-04